Sign in

CIK 0001534120

  • Non-accelerated filer
  • Smaller reporting company

Avalo Therapeutics, Inc.

Sign in to watch
Ticker
AVTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
450705648
Phone
+1 410-522-8707
Business address
1500 LIBERTY RIDGE DRIVE, SUITE 321, WAYNE, PA, 19087
Former names
Cerecor Inc.
  1. 4 Open-market buy 10% owner bought 1,608,000 shares at an average $0.64 ($1,030,179)
  2. 4 Open-market buy 10% owner bought 8,160 shares at an average $3.88 ($31,644)
  3. 4 Open-market buy 10% owner bought 16,899 shares at an average $3.77 ($63,629)
  4. 4 Open-market buy Chief Financial Officer bought 511 shares at $3.42 ($1,748)
  5. 4 Open-market buy CEO and Chairman of the Board bought 4,000 shares at $3.42 ($13,680)
  6. 4 Open-market buy 10% owner bought 14,426 shares at an average $3.91 ($56,440)
  7. 4 Open-market buy 10% owner bought 844 shares at $2.87 ($2,422)
  8. 4 Open-market buy 10% owner bought 2,671 shares at an average $2.79 ($7,464)
  9. 4 Open-market buy 10% owner bought 9,000 shares at an average $2.98 ($26,816)
  10. 4 Open-market buy 10% owner bought 26,621 shares at an average $3.36 ($89,372)
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Open-market buy 10% owner bought 4,379 shares at an average $2.51 ($11,007)
  14. 4 Open-market buy 10% owner bought 25,000 shares at an average $2.77 ($69,365)
  15. 4 Open-market buy 10% owner bought 7,500 shares at an average $2.99 ($22,423)
  16. 4 Open-market buy 10% owner bought 17,500 shares at an average $3.07 ($53,672)
  17. 4 Open-market buy 10% owner bought 25,000 shares at an average $2.95 ($73,874)
  18. 4 Open-market buy 10% owner bought 56,329 shares at an average $2.53 ($142,516)
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 7 of 28 · 552 filings